EoPancreas: New Diabetes Patch Pump and CGM System in Development

$ 19.99

4.5
(766)
In stock
Description

FDA has granted "Breakthrough Device Designation" to South Korean company EoFlow, developing a tubeless patch-pump based Automated Insulin Delivery (AID) system.
FDA has granted Breakthrough Device Designation to South Korean company EoFlow, developing a tubeless patch-pump based Automated Insulin Delivery (AID) system.

Diabetes Café (@Diabetesto) / X

December update on closed-loop systems

Quarterly Update Diabetes Technology

Quarterly Update Diabetes Technology

Shop CGM & Pump Underpatches today - Protect your CGM - Trusted by

Medical devices, smart drug delivery, wearables and technology for the treatment of Diabetes Mellitus - ScienceDirect

Shop CGM & Pump Underpatches today - Protect your CGM - Trusted by thousands like you – Type One Style

Omnipod CGM and Pump Patch - Diabetes UK Shop

Medical devices, smart drug delivery, wearables and technology for the treatment of Diabetes Mellitus - ScienceDirect